Background {#Sec1}
==========

Glossodynia is one of the most common oral symptoms in elderly people. This symptom has various etiologies, including trauma, local infection, anemia, diabetes mellitus, nutritional deficiencies, and trigeminal neuropathy \[[@CR1]--[@CR3]\].

Vitamin B~12~ is one of important nutritional components that affect oral health. Individuals with decreased levels of vitamin B~12~ have been reported to exhibit various oral manifestations such as glossitis, glossodynia, recurrent ulcers, cheilitis, dysgeusia, lingual paresthesia, burning sensations, and pruritus \[[@CR4]--[@CR8]\]. Moreover, 64.3 % of vitamin B~12~ deficiency patients (9 of 14 patients) with oral signs and symptoms were non-anemic and normocytic, suggesting the importance of more detailed blood screening in this patient group \[[@CR9]\].

Most patients with vitamin B~12~ deficiency encountered in dental clinics have a history of gastrectomy due to gastric cancer. These patients have difficulty in absorbing vitamin B~12~ because the source of intrinsic factor, a glycoprotein known to be involved in vitamin B~12~ absorption in the ileum, is partly or totally eliminated by gastrectomy \[[@CR10], [@CR11]\]. However, vitamin B~12~ deficiency has also been observed in elderly patients who have never undergone gastrectomy. It has been reported that certain diseases such as pernicious anemia \[[@CR12], [@CR13]\], gastritis \[[@CR6], [@CR14], [@CR15]\] and thyroid diseases \[[@CR16], [@CR17]\], or some medications \[[@CR18]--[@CR21]\] are related to the absorption process of vitamin B~12~. In patients without a history of gastrectomy, oral manifestations of vitamin B~12~ deficiency could be affected by the related medical conditions and/or medications. Therefore, this difference in etiological factors could result in variations in oral changes according to the presence or absence of a gastrectomy history. However, there have been no reports which compare oral symptoms of vitamin B~12~ deficiency patients with a history of gastrectomy with those without a history of gastrectomy.

In this study, we compared the clinical features of patients with vitamin B~12~ deficiency according to the presence or absence of a gastrectomy history. Probable etiologies of vitamin B~12~ deficiency in patients without a history of gastrectomy were also suggested.

Methods {#Sec2}
=======

Subjects {#Sec3}
--------

This study was a retrospective study based on chart review. Inclusion criteria was low vitamin B~12~ level (\<200 pg/mL) and there was no specific exclusion criteria. Among the patients who were examined and treated by one doctor (HSK) in the Department of Oral Medicine at Seoul National University Dental Hospital (SNUDH) from January 2006 to January 2015, 22 patients were found to have a decreased level of vitamin B~12~ and were included in this study.

Ethics {#Sec4}
------

This chart review study was approved by the Institutional Review Board (IRB) of SNUDH (\#CRI15013). The IRB authorized the exemption of informed consent from the subjects.

Procedures {#Sec5}
----------

The oral symptoms, oral manifestations, blood examination results, and past medical history of each patient were reviewed. In addition, treatments, progression of oral symptoms, and medical consultation results were reviewed. Blood examinations were done during the initial evaluation before the commencement of treatments for oral symptoms. Among the results of blood examination, red blood cell (RBC) count (normal range: male, 4.2-6.3 x 10^6^/μL; female, 4.0-5.4 x 10^6^/μL), hemoglobin (Hb, normal range: male, 13-17 g/dL; female, 12-16 g/dL), hematocrit (Hct, normal range: male, 39-52 %; female, 36-48 %), mean corpuscular volume (MCV, normal range: male, 81-96 fL; female, 79-95 fL), mean corpuscular hemoglobin (MCH, normal range: male, 27-33 pg; female, 26-32 pg), mean corpuscular hemoglobin concentration (MCHC, normal range: 32-36 g/dL), vitamin B~12~ (normal range: 200-1000 pg/mL), folate (normal range: 3-15 ng/mL), and ferritin (normal range: 10-300 ng/mL) were included. When the result of vitamin B~12~ level was '\<25 pg/mL', the value of 25 pg/mL was used for the calculation of mean.

Statistics {#Sec6}
----------

The significance of differences between the two groups was assessed by the Mann--Whitney U test (for continuous variables) and Fisher's exact test (for categorical variables). For each test, a *P* value less than 0.05 was considered statistically significant.

Results {#Sec7}
=======

The demographic characteristics of the patients with vitamin B~12~ deficiency are shown in Table [1](#Tab1){ref-type="table"}. Of the total 22 patients, 11 had a history of gastrectomy (5 men and 6 women) and 11 did not (4 men and 7 women). Of 11 patients with a history of gastrectomy, 10 patients underwent gastrectomy due to gastric cancer and 1 patient due to abdominal rupture caused by a traffic accident. The two groups were not significantly different with respect to age (*P* = 0.323), duration of oral symptoms (*P* = 0.554), and vitamin B~12~ level (*P* = 0.895).Table 1Demographic characteristics of the patients with vitamin B~12~ deficiencyWith a history of gastrectomyWithout a history of gastrectomy*P* value*N* = 11*N* = 11Sex (male/female)5/64/71.000Age (years)\
Mean ± SD (range)62.6 ± 7.6 (51--73)66.9 ± 9.9 (52--85)0.323Symptom duration (months)\
Mean ± SD (range)64.5 ± 61.7 (1--180)37.6 ± 31.9 (6--96)0.554Vitamin B~12~ (pg/mL)\
Mean ± SD (range)74.5 ± 51.2 (25--188)64.2 ± 26.9 (25--123)0.895

The oral symptoms and findings from clinical examinations of the patients are shown in Table [2](#Tab2){ref-type="table"}. The chief complaint was tongue pain for all patients. Other symptoms of the patients with a history of gastrectomy included dry mouth (6/11, 54.5 %) and pain in other intraoral mucosal areas (5/11, 45.5 %). The patients without a history of gastrectomy complained of pain in other intraoral mucosal areas (5/11, 45.5 %), dry mouth (3/11, 27.3 %), and dysgeusia (2/11, 18.2 %). Most of the patients from both groups were taking medications which could have been the cause for dry mouth. In the group with a history of gastrectomy, 1 patient was taking hypnotics and anti-parkinsonism drugs, 1 patient had a history of chemotherapy, and 1 patient was taking hypnotics and had a history of chemotherapy. Such medications and treatment history might be related with the increased incidence of dry mouth in the gastrectomy group. Erythema and depapillation of the tongue were the most common findings (Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}). Patients with erythema of the tongue also had depapillation of the tongue. The patients with a history of gastrectomy showed such oral manifestations more frequently compared with those without a history of gastrectomy. Erythema and depapillation of the tongue were observed in 9 (81.8 %) patients with a history of gastrectomy and 6 (54.5 %) patients without a history of gastrectomy (*P* = 0.361). Angular cheilitis was present in 2 patients with a history of gastrectomy and 1 patient without a history of gastrectomy. Fissured tongue was observed in 8 patients of each group. Two patients (18.2 %) with a history of gastrectomy and 5 patients (45.5 %) without a history of gastrectomy had normal oral mucosa without erythema and depapillation of the tongue, or angular cheilitis (*P* = 0.361) (Figs. [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). Additionally, in the group with a history of gastrectomy, 1 patient showed erythema with erosion on the upper labial mucosa which seemed to be of a traumatic origin on the initial evaluation. The lesion was completely healed at the following appointment. Another patient showed whitish lichenoid lesions with erythema and erosion on both buccal mucosae. One patient without a history of gastrectomy showed erythema on both buccal mucosae which disappeared after antifungal therapy, suggesting the possibility of atrophic candidiasis.Table 2Oral symptoms and clinical findings in the patients with and without a history of gastrectomyNoAge (years)SexChief complaintSymptom duration (months)Dry mouthPain in other oral mucosal areasDysgeusiaETDTACFTOther findingsWith a history of gastrectomy168FTongue pain12+\--++-+-266MTongue pain1-+-++-+erythema with erosion on the upper labial mucosa359FTongue pain48\-\--++-+-473FTongue pain14+\--++-+-553MTongue pain180-+\-\-\--+-655MTongue pain60-+\-\-\-\--whitish lesions with erythema and erosion on both buccal mucosa751FTongue pain156\-\--++-+-865MTongue pain12+\--++\-\--957FTongue pain28++-++\-\--1069MTongue pain54++-++++-1173FTongue pain144+\--++++-Without a history of gastrectomy163FTongue pain84+-+++-+-267FTongue pain72\-\--++\-\--373FTongue pain24\-\--++-+-485MTongue pain12-+\-\-\--+-556FTongue pain16\-\-\-\-\-\-\--680FTongue pain6+\-\-\-\--+-760FTongue pain96-+-++-+erythema on both buccal mucosa870FTongue pain18-+\-\-\-\-\--957MTongue pain18-+-++-+-1073MTongue pain60-++++++-1152MTongue pain8+\-\-\-\--+-ET, Erythema of the tongue; DT, Depapillation of the tongue; AC, Angular cheilitis; FT, Fissured tongueFig. 1Image of the tongue in a patient with a history of gastrectomy (No. 4). Erythema and depapillation of the tongue were observedFig. 2Image of the tongue in a patient without a history of gastrectomy (No. 3). Erythema and depapillation of the tongue were observedFig. 3Image of the tongue in a patient with a history of gastrectomy (No. 5). He had suffered from tongue pain for 15 years, but no pathologic signs were observed on the tongue, except for tongue fissuresFig. 4Image of the tongue in a patient without a history of gastrectomy (No. 4). No pathologic signs were observed on the tongue, except for tongue fissures and slight tongue coatings

The blood examination results of the patients are shown in Table [3](#Tab3){ref-type="table"}. Although there were no significant differences in the mean values of blood examination results between the two groups (*P* = 0.081 - 0.974), it was notable that the patients with a history of gastrectomy tended to be more anemic. The RBC count was decreased in 8 patients (72.7 %) with a history of gastrectomy and 5 patients (45.5 %) without a history of gastrectomy (*P* = 0.387). The Hb level was decreased in 8 patients (72.7 %) with a history of gastrectomy and 3 patients (27.3 %) without a history of gastrectomy (*P* = 0.086). The Hct level was decreased in 7 patients (63.6 %) with a history of gastrectomy and 4 patients (36.4 %) without a history of gastrectomy (*P* = 0.395). The MCV was increased in 6 patients (54.5 %) in each group.Table 3Blood examination results of the patients with and without a history of gastrectomyNoAgeSexSymptom durationRBCHbHctMCVMCHMCHCVit. B~12~FolateFerritin(years)(months)(x10^6^/μL)(g/dL)(%)(fL)(pg)(g/dL)(pg/mL)(ng/mL)(ng/mL)M: 4.2-6.313-1739-5281-9627-3332-36200-10003-1510-300F: 4.0-5.412-1636-4879-9526-32With a history of gastrectomy168F124.111.938.593.228.830.931.09.38.7266M13.010.430.8102.734.733.847.07.437.3359F483.712.537.4102.534.233.488.026.026.8473F143.611.033.994.730.732.4147.06.626.8553M1803.612.535.798.134.335.094.06.036.2655M604.614.841.991.332.235.3188.01.469.4751F1563.311.534.3105.035.033.482.013.0-865M123.713.838.6106.037.935.7\<2514.130.2957F283.68.929.884.025.230.068.017.53.01069M542.611.434.3130.043.133.225.075.0264.61173F1444.211.836.786.928.132.3\<2514.0-Mean62.664.53.611.935.699.533.133.285.617.355.9Without a history of gastrectomy163F843.912.035.993.031.033.4\<2514.445.4267F724.613.238.883.828.534.0123.07.147.8373F244.814.441.787.230.234.662.030.017.7485M122.911.031.6109.038.034.756.08.0144.0556F164.913.540.081.527.533.7107.01.539.7680F63.913.838.9100.035.635.667.015.3-760F963.711.035.496.830.131.147.018.47.5870F184.615.344.596.133.034.443.00.3167.2957M181.56.520.2132.042.732.447.07.6424.11073M604.414.742.096.033.735.160.017.9181.51152M84.315.544.4103.036.034.969.019.827.4Mean66.937.64.012.837.698.033.334.068.112.8110.2RBC, red blood cell count; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; Vit., vitaminWhen the result of vitamin B~12~ level was '\<25 pg/mL', the value of 25 pg/mL was used for the calculation of meanNo significant differences were found between the blood examination results of the patients with and without a history of gastrectomy (the Mann--Whitney U test, *P* \> 0.05)

For management of oral symptoms, topical antifungal therapies were administered to 9 patients with a history of gastrectomy. These therapies included nystatin suspension (4 mL of 100,000 units/mL, 3 times/day, topical) for 5 patients, nystatin suspension with clonazepam (0.5 mg/day, topical) for 1 patient, fluconazole suspension (2.5 mL of 10 mg/mL, 2 times/day, topical) for 1 patient, fluconazole suspension with clonazepam (0.5 mg/day, topical) for 1 patient, and both nystatin and itraconazole suspensions (5 mL of 10 mg/mL, 2 times/day, topical) for 1 patient. One patient was prescribed carboxymethylcellulose (CMC)-based artificial saliva only, and 1 patient was referred to a physician at the first visit. Of the 9 patients who received topical antifungal therapy, 8 showed symptom improvement. All patients with a history of gastrectomy were referred to physicians for further evaluation and management. The results of only 9 patients were available, because 2 patients did not visit after the referrals. Intramuscular injection of vitamin B~12~ was performed in 4 patients and the oral symptoms improved in all. Oral replacement therapy of vitamin B~12~ was performed in 3 patients. The symptoms disappeared in 2 of these patients and partially improved in 1 of these patients. One patient received both vitamin B~12~ injection and oral folate replacement therapy; these treatments led to symptom improvement. One patient received oral vitamin B~12~, ferritin, folate replacement therapy, and vitamin B~12~ injection and this therapy was effective.

Regarding the patients without a history of gastrectomy, topical antifungal therapy (nystatin suspension 4 mL of 100,000 units/mL, 3 times/day, topical) was administered to 6 patients, CMC-based artificial saliva and clonazepam (0.5 - 1.0 mg/day, topical and/or p.o.) to 4 patients, and CMC-based artificial saliva only to 1 patient. Of the 5 patients who did not undergo antifungal therapy, 4 patients did not have any pathologic oral signs, with the exception of fissured tongue. All 6 patients who received topical antifungal therapy and all 4 patients who received CMC-based artificial saliva and clonazepam showed symptom improvement. The one patient who received CMC-based artificial saliva only did not show symptom improvement. Of the 11 patients in this group, 9 were referred to physicians for further evaluation and management. One patient refused the referral after exhibiting significant symptom improvement. The other patient could not be referred because the patient did not come to the clinic on the day that the referral was scheduled. Of the 9 referred patients, 3 were treated with oral vitamin B~12~ replacement therapy, 2 were given vitamin B~12~ injection, and 2 were treated with both oral vitamin B~12~ replacement and injection. All of them showed symptom improvement. One patient was treated with oral vitamin B~12~ and iron replacement therapy; this treatment was effective. The other patient who underwent gastroscopy was diagnosed with early gastric cancer and underwent gastrectomy.

The probable etiologies of vitamin B~12~ deficiency in the patients without a history of gastrectomy are shown in Table [4](#Tab4){ref-type="table"}. Five patients (No. 1, 3, 5, 6, and 8) suffered from gastritis, which might have caused the vitamin B~12~ deficiencies in these patients. Three patients (No. 1, 2, and 4) had diabetes mellitus and were taking related medications, indicating that their diabetes medications were the probable etiologies. One of these patients (No. 1) was also taking thyroid hormone after thyroidectomy due to thyroid cancer. One patient (No. 7) was vegetarian; thus, insufficient intake of nutritional components containing vitamin B~12~ might have caused the deficiency. An additional blood examination performed in the department of hematooncology revealed that one patient (No. 9) had antibodies against the intrinsic factor. Another patient (No. 10) was diagnosed with early gastric cancer based on the result of a gastroscopy performed in the department of internal medicine. One patient (No. 11) underwent gastroscopy, which yielded normal results. No probable etiologic factors were reported in any of the medical histories or additional examinations done at the clinic to which the patient was referred.Table 4Probable etiologies in the patients without a history of gastrectomyNoAge (years)SexSymptom duration (months)Probable etiology of vitamin B~12~ deficiency163F84Medications for diabetes mellitus and Gastritis267F72Medications for diabetes mellitus373F24Gastritis485M12Medications for diabetes mellitus556F16Gastritis680F6Gastritis760F96Vegetarian diet870F18Gastritis957M18Antibodies to intrinsic factor1073M60Early gastric cancer1152M8Unknown

Among 11 patients with a history of gastrectomy, 2 patients (No. 3 and 8) had gastritis, 2 patients (No. 4 and 11) had diabetes mellitus and were taking related medications, and 1 patient (No. 1) was taking thyroid hormone for hypothyroidism.

Discussion {#Sec8}
==========

Our results showed that oral signs and symptoms and blood examination abnormalities were more common and also more severe in patients with a history of gastrectomy. Resection of the gastrointestinal tract was the definite cause although some of these patients had other medical conditions which might have played a role in the pathogenesis of the vitamin B~12~ deficiency. On the other hand, in patients without a history of gastrectomy, the severity and duration of diseases and/or the dose and duration of medication intake could have affected the clinical and laboratory results. Interestingly, 2 patients with a history of gastrectomy and 5 patients without a history of gastrectomy did not show any significant pathologic oral signs, except for tongue fissures. Decreased Hb and Hct levels were more common in patients with a history of gastrectomy compared to those without a history of gastrectomy. The probable etiologies for the vitamin B~12~ deficiencies in the patients without a history of gastrectomy were gastritis, diabetes medications, a vegetarian diet, antibodies to the intrinsic factor, and early gastric cancer.

Atrophic gastritis, a very common disease with a high prevalence in elderly patients, has been known to be one of the most common causes of vitamin B~12~ deficiency \[[@CR6], [@CR14], [@CR15]\]. Chronic inflammation of the stomach wall causes atrophy of the gastric mucosa and decreased secretion of gastric acid, which can result in malabsorption of vitamin B~12~. Moreover, medications for gastritis, such as proton pump inhibitors, have been reported to inhibit gastric acid production, which might also cause malabsorption of vitamin B~12~ \[[@CR18], [@CR20]\].

Metformin is one of the most commonly prescribed drugs for type 2 diabetes and is well known to be associated with vitamin B~12~ deficiency \[[@CR19], [@CR21], [@CR22]\]. Metformin inhibits gluconeogenesis, decreases hepatic glucose output, and increases insulin sensitivity. One of the most commonly reported side effects of metformin is gastrointestinal disorders, including reduced vitamin B~12~ absorption. Metformin disturbs the metabolism of calcium which is one of the necessary elements for the body to absorb vitamin B~12~ \[[@CR22]\].

Although pernicious anemia is uncommon in Asians including Korean ethnicity \[[@CR23], [@CR24]\], this disease is another cause of vitamin B~12~ deficiency \[[@CR12], [@CR13]\]. Pernicious anemia is an autoimmune disease characterized by the absence of intrinsic factor, a glycoprotein that is necessary for vitamin B~12~ absorption \[[@CR25], [@CR26]\]. This condition prevents the normal absorption of vitamin B~12~, thereby resulting in vitamin B~12~ deficiency. Vitamin B~12~ is usually found in foods of animal origin, such as meat, poultry, fish, and eggs \[[@CR7]\]. Therefore, a strict vegetarian diet could cause a vitamin B~12~ deficiency, and vitamin B~12~ replacement is recommended for vegetarians. Thyroid diseases have also been known to be associated with vitamin B~12~ deficiency \[[@CR16], [@CR17]\]. Thyroid hormone stimulates erythropoiesis and anemia frequently develops in patients with thyroid hormone disorders. Megaloblastic anemia has been reported to be related to thyroid diseases, but this relationship is still controversial \[[@CR27], [@CR28]\].

The finding that 5 of 11 vitamin B~12~ deficiency patients without a history of gastrectomy complained of tongue pain in the absence of any significant pathologic oral signs suggests that blood examinations, including vitamin B~12~ measurements, are mandatory for patients with glossodynia. Such examinations are important even for patients without a history of gastrectomy and for patients without any pathologic oral signs. Furthermore, the finding that 1 patient had early gastric cancer implies that gastroscopy is necessary for patients who have not undergone gastroscopy regularly.

Antifungal therapy was effective especially in patients with oral signs such as tongue erythema and depapillation, or angular cheilitis. Since vitamin B~12~ deficiency can cause an anemic state in the body by attenuating the immune system, patients with vitamin B~12~ deficiency are more susceptible to opportunistic infections such as candidiasis \[[@CR29]\]. Some patients treated with clonazepam exhibited symptom improvement. Clonazepam is the preferred drug for treating burning mouth syndrome and has been widely used as a topical agent, an oral agent, and a combined way \[[@CR30]--[@CR33]\]. Vitamin B~12~ deficiency has been reported to be related to peripheral neuropathy \[[@CR7], [@CR34]\]. Thus, some of the oral symptoms in our patients may be related to neuropathic changes of the trigeminal nerve.

As expected, vitamin B~12~ replacement therapy was effective for most patients, regardless of their gastrectomy history. Interestingly, oral vitamin B~12~ replacement therapy was also effective for the patients with a history of gastrectomy. Orally taken vitamin B~12~ can be absorbed by an intrinsic factor-independent passive diffusion pathway. Oral vitamin B~12~ replacement has been reported to be effective and safe treatment, even in patients with a history of total gastrectomy \[[@CR10]\].

Our study showed that the most common oral symptom in patients with vitamin B~12~ deficiency was tongue pain and the most common findings were erythema and depapillation of the tongue. These oral signs and symptoms and blood examination abnormalities were less common and also less severe in patients without a history of gastrectomy than those with a history of gastrectomy. Oral symptoms responded to antifungal therapy. Clonazepam could be of additional help. Vitamin B~12~ replacement therapy was effective. Patients without a history of gastrectomy exhibited many probable etiologic factors, such as gastritis, medications for diabetes and/or gastritis, a vegetarian diet, autoimmunity, and gastric cancer.

Conclusions {#Sec9}
===========

It is essential that complete medical histories including medication information should be obtained from all patients complaining of tongue pain, irrespective of their oral findings or gastrectomy history. Gastroscopy is strongly recommended for all patients with vitamin B~12~ deficiency who do not have a history of gastrectomy.
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=============
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